Chinese scientists and clinicians have developed a learning artificial intelligence system which can diagnose and identify cancerous prostate samples as accurately as any pathologist.
This holds out the possibility of streamlining and eliminating variation in the process of cancer diagnosis. It may also help overcome any local shortage of trained pathologists. In the longer term it may lead to automated or partially-automated prostate cancer diagnosis.
Prostate cancer is the most common male cancer, with around 1.1m diagnoses ever year, worldwide1 (for comparison, that’s around x4 the number of men who live in Copenhagen). Confirmation of the diagnosis normally requires a biopsy sample, which is then examined by a pathologist. Now an artificial intelligence learning system, presented at the European Association of Urology congress in Copenhagen, has shown similar levels of accuracy to a human pathologist. In addition, the software can accurately classify the level of malignancy of the cancer, so eliminating the variability which can creep into human diagnosis.
“This is not going to replace a human pathologist” said research leader Hongqian Guo (Nanjing, China), “We still need an experienced pathologist to take responsibility for the final diagnosis. What it will do is help pathologists make better, faster diagnosis, as well as eliminating the day-to-day variation in judgement which can creep into human evaluations”.
Prof. Guo’s group took 918 prostate whole mount pathology section samples from 283 patients, and ran these through the analysis system, with the software gradually learning and improving diagnosis. These pathology images were subdivided into 40,000 smaller samples; 30,000 of these samples were used to ‘train’ the software, the remaining 10,000 were used to test accuracy – the results showed an accurate diagnosis in 99.38% of cases (using a human pathologist as a ‘gold standard’), which is effectively as accurate as the human pathologist. They were also able to identify different Gleason Grades in the pathology sections using AI; ten whole mount prostate pathology sections have been tested so far, with similar Gleason Grade in the AI and human pathologist’s diagnosis. The group has not started testing the system with human patients.
Prof. Guo continued “The system was programmed to learn and gradually improve how it interpreted the samples. Our result show that the diagnosis the AI reported was at a level comparable to that of a pathologist. Furthermore, it could accurately classify the malignant levels of prostate cancer. Until now, automated systems have had limited clinical value, but we believe this is the first automated work to offer an accurate reporting and diagnosis of prostate cancer. In the short-term, this can offer a faster throughput, plus a greater consistency in cancer diagnosis from pathologist to pathologist, hospital to hospital, country to country.
Artificial intelligence is advancing at an amazing rate – you only need to look at facial recognition on smartphones, or driverless cars. It is important that cancer detection and diagnosis takes advantage of these changes”.
Commenting, Professor Rodolfo Montironi (Professor of Pathology, Polytechnic University of the Marche, Ancona, Italy) said:
“This is interesting work which shows how artificial intelligence will increasingly step into clinical practice. This may be very useful in some areas where there is a lack of trained pathologists. Like all automation, this will lead to a lesser reliance on human expertise, but we need to ensure that the final decisions on treatment stay with a trained pathologist. The really important thing though, is that we ensure the highest standard of patient care. The future will be interesting”. Professor Montironi was not involved in this work – this is an independent comment.
Learn more: Smart software can diagnose prostate cancer as well as a pathologist
The Latest on: Artificial intelligence diagnostics
[google_news title=”” keyword=”artificial intelligence diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial intelligence diagnostics
- Radiomics and artificial intelligence in oncology imagingon July 29, 2024 at 6:08 am
Imaging plays a key role in oncology, whether at the diagnostic stage, in the preparation of treatment, the evaluation of the response, or in terms of prognosis. The progress made in image acquisition ...
- Hobart-based doctors use artificial intelligence to diagnose gallstones in the common bile ducton July 29, 2024 at 12:59 am
A team of Hobart-based doctors has successfully used artificial intelligence to diagnose gallstones in the common bile duct or choledocholithiasis.
- Artificial Intelligence, Social Responsibility, and the Roles of the Universityon July 25, 2024 at 9:36 am
How universities can influence socially responsible use of AI technology development and use.
- NIH study shows AI scores high in diagnostic quiz, but still can't show its workon July 23, 2024 at 4:00 am
A study by the National Institutes of Health (NIH) found that artificial intelligence could help accurately diagnose patients—but the large language model still stumbled when it came to clearly ...
- EU Artificial Intelligence Regulation Published - What You Need to Knowon July 22, 2024 at 5:00 pm
Regarding medical devices and in vitro diagnostic medical devices ... All national supervisory authorities will be represented in the European Artificial Intelligence Committee, which will act as a ...
- Study finds how genetic diagnostics of ultra-rare diseaseson July 22, 2024 at 11:02 am
Most rare diseases are caused by genetics. A molecular genetic diagnosis can be made more quickly and readily by identifying the underlying genetic change, for instance by exome sequencing (ES). The ...
- Genetic diagnostics of ultra-rare diseases: Large multicenter study identifies 34 new genetic diseaseson July 22, 2024 at 7:13 am
The majority of rare diseases have a genetic cause. The underlying genetic alteration can be found more and more easily, for example, by means of exome sequencing (ES), leading to a molecular genetic ...
- Artificial intelligence detects cancer with 25% greater accuracy than doctors in UCLA studyon July 21, 2024 at 5:42 am
A new study from UCLA found that an AI tool identified prostate cancer with 84% accuracy — compared to 67% accuracy for cases detected by physicians. Experts weigh in on the findings.
- 3 Beaten-Down Artificial Intelligence (AI) Stocks to Buy Hand Over Fiston July 19, 2024 at 10:35 pm
Snowflake will benefit from a growing need for data warehousing services. Datadog's AI-powered diagnostics platform is still expanding. Upstart's AI-driven lending services will flourish again as ...
via Bing News